Quarterly report pursuant to Section 13 or 15(d)

Noncontrolling Interest

v3.19.2
Noncontrolling Interest
6 Months Ended
Jun. 30, 2019
Noncontrolling Interest [Abstract]  
NONCONTROLLING INTEREST

NOTE 17 – NONCONTROLLING INTEREST

 

As of June 30, 2019, Dr. Yu Zhou, director and Co-Chief Executive Officer of GenExsome, who owned 40% of the equity interests of GenExosome, which is not under the Company's control. The following is a summary of noncontrolling interest activities in the six months ended June 30, 2019.

 

    Amount  
Noncontrolling interest at December 31, 2018   $ (862,200 )
Net loss attributable to noncontrolling interest     (180,712 )
Foreign currency translation adjustment attributable to noncontrolling interest     702  
Noncontrolling interest at June 30, 2019   $ (1,042,210 )